跳至主要内容
临床试验/IRCT201212178698N5
IRCT201212178698N5已完成未知

Impact of L-carnitine on contrast induced nephropathy in patients undergoing elective Percutaneous Coronary Intervention(PCI)

Tehran University of Medical Sciences0 个研究点目标入组 320 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
320

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 90 years(—)
性别
Male

入选标准

  • Patients with ischemic heart disease that have more than 50 percent occlusion in angiography findings and candidates for elective Pecrcutaneous Coronary Intevention.Exclusion criteria: cardiogenic shock;ST Elevation Myocardial Infarction;pregnant and lactating womens;patients under 18 years;immunologic or hematologic disorders;current infection;chronic kidney disease;serum creatinine above 2.5 mg/dl;hypothyroidism;epilepsy or convulsion;chronic liver disease;cancer

排除标准

  • 未提供

研究者

相似试验

Impact of l-carnitine on contrast induced nephropathy | 临床试验